Guiding Novel Neurologic Drug Approvals
The FDA’s review of drug and biological products in this medication class is critical, as a brain impairment impacts between 6.5% and 7.9% of adults in the United States.
Brain Changes Signal Nascent Alzheimer’s
Scientists from the University of Eastern Finland have identified alterations occurring in the human brain that signal the early stages of this common neurogenerative disease.
To Dose or Not to Dose?
Prescribing low-dose aspirin for preventing secondary cardiovascular disease is well established, but its safety and efficacy in primary prevention remains open to debate.
Opioid Therapy–Associated Cardiovascular Effects
In patients taking prescribed opioids, an increased cardiovascular event rate has recently been reported in older adults..
Perils of Mixing Opioids, Benzodiazepines
Opioid-related research developments of interest to pharmacists.
Copyright © 2000 - 2026 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.